Systematic reviews of randomized controlled trials: the need for complete data

Area of Science:

• Clinical Research Methodology
• Evidence-Based Medicine
• Biostatistics

Background:

• Evaluating relative treatment effectiveness is crucial for clinical practice.
• Moderate treatment differences are clinically important but hard to assess due to chance and bias.
• Randomized evidence from trials and meta-analyses is essential.

Purpose of the Study:

• To outline methods for reliable evaluation of comparative treatment effectiveness.
• To highlight the importance of minimizing bias in treatment evaluation.
• To present the rationale and techniques for individual patient data meta-analysis.

Main Methods:

• Collecting extensive randomized evidence through prospective randomized controlled trials.
• Conducting meta-analyses of past randomized trials.
• Utilizing individual patient data meta-analysis for comprehensive analysis.

Main Results:

• Individual patient data meta-analysis minimizes problems associated with published or aggregate data.
• This approach allows for more in-depth analyses.
• It enhances the reliability of evaluating moderate treatment differences.

Conclusions:

• Appropriate methodology, particularly minimizing bias, is vital for reliable treatment effectiveness evaluation.
• Individual patient data meta-analysis is presented as a gold standard method.
• This technique offers significant advantages over relying solely on published or aggregate data.